ARTICLE
8 September 2017

The Ministry Of Information & Broadcasting Issues Advisory For TV Channels Against The Misleading Advertisements Of AYUSH Products/Drugs

CC
Clyde & Co

Contributor

Clyde & Co  logo
Clyde & Co is a leading, sector-focused global law firm with 415 partners, 2200 legal professionals and 3800 staff in over 50 offices and associated offices on six continents. The firm specialises in the sectors that move, build and power our connected world and the insurance that underpins it, namely: transport, infrastructure, energy, trade & commodities and insurance. With a strong focus on developed and emerging markets, the firm is one of the fastest growing law firms in the world with ambitious plans for further growth.
In order to protect the citizens from misleading advertisements and health risks, the Ministry of Information & Broadcasting, Government of India issued an advisory dated 12th July, 2017...
India Media, Telecoms, IT, Entertainment
To print this article, all you need is to be registered or login on Mondaq.com.

In order to protect the citizens from misleading advertisements and health risks, the Ministry of Information & Broadcasting, Government of India issued an advisory dated 12th July, 2017, to all the television channels for ensuring strict compliance of the provisions of the Drug and Magic Remedies (Objectionable Advertisements) Act, 1954, and the Drugs & Cosmetic Act, 1940. The advisory states that the aforesaid Acts and the rules thereunder should be adhered by the television channels while telecasting advertisements. As per the advisory, in relation to the Ayurvedic, Siddha, Unani and Homeopathic (AYUSH) products/drugs, the television channels are advised to advertise only AYUSH products/drugs that have valid license issued by the Ministry of AYUSH or the State Drug Licensing Authorities. The Ministry of AYUSH is of the view that some channels carry advertisements with exaggerated or improper claims of AYUSH products/drugs which mislead consumers and pose potential health risks with self-medication.

This update is authored by Clasis Law, Clyde & Co's associated firm in India

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More